Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
about
Proximity extension of circular DNA aptamers with real-time protein detection.Aptamers in TherapeuticsFrom selection hits to clinical leads: progress in aptamer discoveryRecent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingNucleic acid aptamers: research tools in disease diagnostics and therapeuticsNucleic acid aptamers: an emerging frontier in cancer therapyDevelopment of Cell-SELEX Technology and Its Application in Cancer Diagnosis and TherapyAptamer-Drug ConjugatesIdentification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2Inhibition of cell proliferation by an anti-EGFR aptamerStructural computational modeling of RNA aptamersDiagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubblesMagnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided ApproachesMolecular imaging agents: impact on diagnosis and therapeutics in oncologySpecific capture and temperature-mediated release of cells in an aptamer-based microfluidic device.Aptamers and their biological applicationsSelection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cellsAmyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.Cell-specific aptamers for targeted therapies.The Combination of Computational and Biosensing Technologies for Selecting Aptamer against Prostate Specific Antigen.Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing.Laser ablation-based one-step generation and bio-functionalization of gold nanoparticles conjugated with aptamers.Aptamer-targeted cell-specific RNA interferenceMultifunctional aptamer-miRNA conjugates for targeted cancer therapy.Formulation/preparation of functionalized nanoparticles for in vivo targeted drug delivery.GCPII imaging and cancer.Strategies for the discovery of therapeutic aptamers.Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersCell-type-specific, Aptamer-functionalized Agents for Targeted Disease TherapyMultilayer coating of gold nanorods for combined stability and biocompatibility.ABC transporters in CSCs membranes as a novel target for treating tumor relapse.Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.Aptamers from cell-based selection for bioanalytical applicationsIn vitro selection of RNA aptamer and specific targeting of ErbB2 in breast cancer cells.Nucleotide bias observed with a short SELEX RNA aptamer libraryAptamers selected by cell-SELEX for application in cancer studies.Nucleic acid aptamers: clinical applications and promising new horizonsA general RNA motif for cellular transfection.Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis.
P2860
Q24791851-B62B27CD-89E6-44D9-88A7-08C49FF66EA9Q26738413-FEC8978A-99B9-4A97-81EC-B04B634C6D69Q26752799-5CA6A087-2DC8-4AF6-B890-1298360E4455Q26778234-0E862D14-21FF-499E-BE3A-F80401389CB9Q26824321-2F341A08-77D6-47AE-8025-960FD264639FQ26849947-B50BFDF8-DEC2-4C89-8D05-9E67DCF251E0Q28080168-97A2199E-91B2-495A-81D9-EDAF7ACFA5E1Q28468281-63DF492A-B3BF-4B42-9C9B-CF5A8A71A271Q28484118-AFB1A609-21FE-4566-8FC6-B387D5C57C6BQ28743866-51156287-08D5-472E-BEBF-CD47D031A3A5Q28828891-60478756-9FAC-465B-B6E0-D2CAF8063069Q28829750-50749418-22EE-4829-AC8B-630B759D5911Q30354223-765B0E7E-AC32-4F01-B8C6-C83792EF7807Q30433423-CA86A793-D225-4943-BECE-4360FCC9ED7DQ30440489-5BF00491-91CA-4842-9F5F-4E438ACC62FBQ30470240-7D628407-987B-43CD-B3A3-F675D03BFF77Q30859838-3D295E38-CB61-4BC1-84F5-C29FB33A09D4Q33392254-17FA64DD-22E1-4EC2-AF07-3C34DABFDB1FQ33432043-37CF4F38-3BD1-4251-B97C-F74BCDB53913Q33552121-A8A733FD-672E-419D-933C-81338E9E3EB7Q33598723-63FF88FD-E6FC-4288-A88F-A0E989A957A7Q33655937-3F5AEB80-FEB7-4E6B-BEA3-B51F8E13488EQ33669424-24451379-8AEC-4863-A548-E97308AA57BAQ33717239-2646AA3D-AD04-4AEF-9C6D-82FD1BC0AF09Q33724277-1A95BAB9-8C73-41A4-A8E6-2A7512D467F1Q33760895-8957BF0E-A81F-405F-A0BF-D13475063327Q33827632-1DA19C8F-8917-43A0-9171-8BF992345F91Q33831862-A632849B-5849-46BB-8C4E-9795ABEA3D4AQ33832781-9E543989-B4CE-4CEC-9C0E-12A8FDAA2718Q33834772-08AEB444-8562-4D4A-900A-7C88B92DE2E2Q33841048-01474D46-23AA-46A5-A316-E76ED2E914B8Q33879326-FC4E6202-A2ED-45F8-9805-45360AFA4B65Q33893647-E48B3A2D-6E1D-4B09-8E30-7D09BA029F33Q33920514-DF47F69B-9EC3-4FD7-A409-66E176FB9155Q33958666-B895E5E2-2E4A-4677-90EC-E7D53B702C70Q33972934-EB84E021-2E1B-46DC-AF9D-A54CC0F87478Q34006173-8A022BA2-756A-442C-BAE9-580C66B93405Q34028112-D6243290-42FE-46A8-964B-96E3BC6D566AQ34123063-EB4AB9AC-A7D8-46C3-9753-AD00BACEA259Q34240731-BFC4CEA3-8484-4B7F-9515-F3725B9790A5
P2860
Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identification and characteriz ...... ate-specific membrane antigen.
@ast
Identification and characteriz ...... ate-specific membrane antigen.
@en
type
label
Identification and characteriz ...... ate-specific membrane antigen.
@ast
Identification and characteriz ...... ate-specific membrane antigen.
@en
prefLabel
Identification and characteriz ...... ate-specific membrane antigen.
@ast
Identification and characteriz ...... ate-specific membrane antigen.
@en
P2093
P1433
P1476
Identification and characteriz ...... ate-specific membrane antigen.
@en
P2093
Brian J Hicke
Donald S Coffey
Shawn E Lupold
P304
P407
P577
2002-07-01T00:00:00Z